Thursday, April 2, 2015

Deals

Intrexon-Merck KGaA Team Up

April 1, 2015 · Leave a Comment 

Intrexon Corporation (XON – Snapshot Report) and Merck KGaA’s biopharmaceutical business Merck Serono announced the signing of an exclusive strategic collaboration and license agreement for the development and commercialization of chimeric antigen receptor T-cell (CAR-T) cancer therapies. Terms of the Deal Per the deal, Intrexon will receive research funding from Merck KGaA for the first two targets of interest selected by the latter. Moreover, Intrexon is eligible to receive up to $826 million in development, regulatory and commercial milestones and tiered royalties on product sales, apart... [Read the full story]

Deal News

Intrexon-Merck KGaA Team Up

April 1, 2015 · Leave a Comment 

Intrexon Corporation (XON – Snapshot Report) and Merck KGaA’s biopharmaceutical business Merck Serono announced the signing of an exclusive strategic collaboration and license agreement for the development and commercialization of chimeric antigen receptor T-cell (CAR-T) cancer therapies. Terms of the Deal Per the deal, Intrexon will receive research funding from Merck KGaA for the first two targets of interest selected by the latter. Moreover, Intrexon is eligible to receive up to $826 million in development, regulatory and commercial milestones and tiered royalties on product sales, apart... [Read the full story]

Legal

Semafone and Eckoh agree to settlement

March 19, 2015 · Leave a Comment 

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed to a confidential settlement of their dispute over alleged infringement and invalidity of Semafone’s UK Patent (No. GB 2,473,376), to the mutual benefit of both parties.  Under the settlement, Semafone has granted a worldwide licence to their granted patents, trademarks and patent applications covering certain dual tone multi-frequency (“DTMF”) masking methods of taking secure payments over the phone, for the benefit of Eckoh, its customers and suppliers. In consideration of the licence, Eckoh... [Read the full story]

Bio

Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement

April 1, 2015 · Leave a Comment 

  SAN DIEGO, March 31, 2015 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it has entered into an exclusive collaboration and licensing agreement for the development and commercialization of its VMAT2 inhibitor, NBI-98854, in Japan and other select Asian markets with Mitsubishi Tanabe Pharma Corporation (TSE: 4508). Mitsubishi Tanabe intends to initially develop NBI-98854 in Japan for the chorea associated with Huntington’s disease and tardive dyskinesia. Neurocrine retains full commercial rights to NBI-98854 in North America, Europe and other countries... [Read the full story]

University Tech Transfer

Panther Biotechnology License Agreement With Northwestern University

April 1, 2015 · Leave a Comment 

  Panther Biotechnology, Inc. (OTC PINK: PBYA), a biotechnology company specializing in the development of enhanced therapeutics for the treatment of neoplastic and autoimmune disorders, is pleased to announce today that it has entered into an exclusive global license agreement with Northwestern University. Under the terms of the agreement, Panther has licensed from Northwestern University the rights to develop and commercialize new technologies to enhance efficacy and decrease toxic side effects of a novel category of anti-cancer drugs. The licensed compounds, called Numonafides, are optimized... [Read the full story]

People

IP Industry: we start here

March 8, 2015 · Leave a Comment 

In 2007, we set out to change the world of intellectual property, and how innovation and ideas were exchanged among IP owners and those that desired IP. We knew there were significant headwinds with an entrenched, decades-old ecosystem of long held beliefs about the “way things ought to be done” and who were we to come along and try to change things. None of this did anything to deter us; it drove us even harder. Not to gloat or brag, but many of the world’s LARGEST IP Owners and Transactors are now our customers- more on that in later posts.  They see the same future. IP Attorneys said... [Read the full story]

Deals

Intrexon-Merck KGaA Team Up

Intrexon Corporation (XON – Snapshot Report) and Merck KGaA’s biopharmaceutical business Merck Serono announced the signing of an exclusive strategic collaboration and license agreement for the development and commercialization of chimeric antigen receptor T-cell (CAR-T) cancer therapies. Terms of the Deal Per the deal, Intrexon will receive... Read more of this article


Neurocrine Biosciences and Mitsubishi Tanabe Pharma Announce Agreement

  SAN DIEGO, March 31, 2015 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it has entered into an exclusive collaboration and licensing agreement for the development and commercialization of its VMAT2 inhibitor, NBI-98854, in Japan and other select Asian markets with Mitsubishi Tanabe Pharma Corporation (TSE:... Read more of this article


Solasia buys exclusive commercialization rights from Camurus

  Camurus AB (Camurus) and Solasia Pharma K.K. (Solasia) jointly announced that they have entered into a license and distribution agreement for episil oral liquid, a unique and effective treatment for the pain of oral mucositis, a treatment-limiting side effect of some cancer therapies, as well as other oral lesions. As part of the agreement Solasia... Read more of this article


Sawgrass Technologies and J-Teck3 Sign New License Agreement

  Sawgrass Technologies, Inc. and J-Teck3 of Italy have entered into a new long term license agreement under which J-Teck3, as an authorized Sawgrass licensee, will continue to sell digital inks for sublimation imaging. Sawgrass is an industry leading developer of breakthrough printing technologies. J-Teck3 is a leading global supplier of high... Read more of this article


Panther Biotechnology License Agreement With Northwestern University

  Panther Biotechnology, Inc. (OTC PINK: PBYA), a biotechnology company specializing in the development of enhanced therapeutics for the treatment of neoplastic and autoimmune disorders, is pleased to announce today that it has entered into an exclusive global license agreement with Northwestern University. Under the terms of the agreement, Panther... Read more of this article


Acacia Subsidiary Enters into Patent License Agreement with DePuy Synthes, Inc.

  NEWPORT BEACH, Calif., Mar 31, 2015 (BUSINESS WIRE) — Acacia Research Corporation ACTG, -1.04% announced today that its Bonutti Skeletal Innovations LLC subsidiary has entered into a settlement and patent license agreement with DePuy Synthes, Inc. and DePuy Orthopaedics, Inc. The agreement resolves litigation that was pending in the United... Read more of this article


WAMGROUP acquires Enviro-Care

  ROCKFORD, Ill. — Enviro-Care Company has been acquired by the WAMGROUP®, with headquarters in Modena, Italy, according to a press release. First entering into the conveying market in 1969, WAMGROUP, a multinational company, quickly expanded into all “facets of bulk solids handling equipment,” stated the release WAMGROUP purchased SAVI... Read more of this article


RedHill Biopharma Acquires From Apogee Biotech

  TEL-AVIV, Israel, March 31, 2015 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (“RedHill”), an Israeli biopharmaceutical company primarily focused on late clinical-stage, proprietary, orally-administered drugs for inflammatory and gastrointestinal diseases, including gastrointestinal cancers, and Apogee... Read more of this article


Acacia Subsidiaries Enter into Patent License Agreements with Sony Mobile Communications Inc.

  NEWPORT BEACH, Calif., Mar 31, 2015 (BUSINESS WIRE) — Acacia Research Corporation ACTG, -0.03% announced today that its Saint Lawrence Communications LLC and Saint Lawrence Communications GmbH subsidiaries have entered into patent license agreements with Sony Mobile Communications Inc.  Read More →


Applied BioCode Licenses to PerkinElmer

  SANTA FE SPRINGS, Calif.–(BUSINESS WIRE)–Applied BioCode announced today that it has expanded its existing License and Supply Agreement for its multiplex Barcoded Magnetic Bead (BMB) technology with PerkinElmer. The non-exclusive license from Applied BioCode provides PerkinElmer with access to Applied BioCode’s 4,096-plex BMB patents... Read more of this article


More Posts From Deals

Legal

Semafone and Eckoh agree to settlement

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed... 


Iteris, Wavetronix Settle Patent Infringement Litigation

  SANTA ANA, Calif.–Iteris, Inc. (NYSE MKT: ITI), a leader in providing... 


More Posts From Legal

University Tech Transfer

Panther Biotechnology License Agreement With Northwestern University

  Panther Biotechnology, Inc. (OTC PINK: PBYA), a biotechnology company specializing... 


Avalanche Biotechnologies (AAVL) Enters Exclusive License Agreement with University of Washington

  Avalanche Biotechnologies (Nasdaq: AAVL) today announced that it has entered... 


More Posts From University Tech Transfer